306 related articles for article (PubMed ID: 21432852)
21. The molecular genetics of Marfan syndrome and related microfibrillopathies.
Robinson PN; Godfrey M
J Med Genet; 2000 Jan; 37(1):9-25. PubMed ID: 10633129
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.
Judge DP; Biery NJ; Keene DR; Geubtner J; Myers L; Huso DL; Sakai LY; Dietz HC
J Clin Invest; 2004 Jul; 114(2):172-81. PubMed ID: 15254584
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.
Dietz HC; Pyeritz RE
Hum Mol Genet; 1995; 4 Spec No():1799-809. PubMed ID: 8541880
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
25. Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies.
Hayward C; Brock DJ
Hum Mutat; 1997; 10(6):415-23. PubMed ID: 9401003
[TBL] [Abstract][Full Text] [Related]
26. A new mouse model for marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of Fbn1 expression.
Lima BL; Santos EJ; Fernandes GR; Merkel C; Mello MR; Gomes JP; Soukoyan M; Kerkis A; Massironi SM; Visintin JA; Pereira LV
PLoS One; 2010 Nov; 5(11):e14136. PubMed ID: 21152435
[TBL] [Abstract][Full Text] [Related]
27. Fibrillin-1 mgΔ(lpn) Marfan syndrome mutation associates with preserved proteostasis and bypass of a protein disulfide isomerase-dependent quality checkpoint.
Meirelles T; Araujo TLS; Nolasco P; Moretti AIS; Guido MC; Debbas V; Pereira LV; Laurindo FR
Int J Biochem Cell Biol; 2016 Feb; 71():81-91. PubMed ID: 26718974
[TBL] [Abstract][Full Text] [Related]
28. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
29. Nanoscale Structural Comparison of Fibrillin-1 Microfibrils Isolated from Marfan and Non-Marfan Syndrome Human Aorta.
Șulea CM; Mártonfalvi Z; Csányi C; Haluszka D; Pólos M; Ágg B; Stengl R; Benke K; Szabolcs Z; Kellermayer MSZ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108724
[TBL] [Abstract][Full Text] [Related]
30. [Contribution of genetics to pathogenicity and diagnosis of Marfan syndrome].
Boileau C; Collod G; Bonnet D
Arch Mal Coeur Vaiss; 1997 Dec; 90(12 Suppl):1707-12. PubMed ID: 9587455
[TBL] [Abstract][Full Text] [Related]
31. Genetic fibrillinopathies: new insights in molecular diagnosis and clinical management.
Loeys BL; Matthys DM; de Paepe AM
Acta Clin Belg; 2003; 58(1):3-11. PubMed ID: 12723256
[TBL] [Abstract][Full Text] [Related]
32. Fibrillin-1 Regulates Arteriole Integrity in the Retina.
Alonso F; Li L; Fremaux I; Reinhardt DP; Génot E
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291539
[TBL] [Abstract][Full Text] [Related]
33. Variability of aortic stiffness is not associated with the fibrillin 1 genotype in patients with Marfan's syndrome.
De Backer J; Nollen GJ; Devos D; Pals G; Coucke P; Verstraete K; van der Wall EE; De Paepe A; Mulder BJ
Heart; 2006 Jul; 92(7):977-8. PubMed ID: 16775108
[No Abstract] [Full Text] [Related]
34. A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.
Liu D; Wang CJ; Judge DP; Halushka MK; Ni J; Habashi JP; Moslehi J; Bedja D; Gabrielson KL; Xu H; Qian F; Huso D; Dietz HC; Germino GG; Watnick T
J Am Soc Nephrol; 2014 Jan; 25(1):81-91. PubMed ID: 24071006
[TBL] [Abstract][Full Text] [Related]
35. Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a GxxPG-containing fibrillin-1 fragment.
Guo G; Booms P; Halushka M; Dietz HC; Ney A; Stricker S; Hecht J; Mundlos S; Robinson PN
Circulation; 2006 Oct; 114(17):1855-62. PubMed ID: 17030689
[TBL] [Abstract][Full Text] [Related]
36. Mouse models of genetic diseases resulting from mutations in elastic fiber proteins.
Dietz HC; Mecham RP
Matrix Biol; 2000 Nov; 19(6):481-8. PubMed ID: 11068202
[TBL] [Abstract][Full Text] [Related]
37. Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells.
Mariko B; Ghandour Z; Raveaud S; Quentin M; Usson Y; Verdetti J; Huber P; Kielty C; Faury G
Am J Physiol Cell Physiol; 2010 Nov; 299(5):C977-87. PubMed ID: 20686071
[TBL] [Abstract][Full Text] [Related]
38. Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders.
Milewicz DM
Tex Heart Inst J; 1994; 21(1):22-9. PubMed ID: 8180508
[TBL] [Abstract][Full Text] [Related]
39. Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome.
Gould RA; Sinha R; Aziz H; Rouf R; Dietz HC; Judge DP; Butcher J
PLoS One; 2012; 7(9):e44639. PubMed ID: 22984535
[TBL] [Abstract][Full Text] [Related]
40. Marfan syndrome caused by a novel FBN1 mutation with associated pigmentary glaucoma.
Kuchtey J; Chang TC; Panagis L; Kuchtey RW
Am J Med Genet A; 2013 Apr; 161A(4):880-3. PubMed ID: 23444230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
